RegenETP, Inc. (RGTPQ)

Market Cap	1.12M
Revenue (ttm)	73.00K -98.7%
Net Income	-8.31M
EPS	-1.09
Shares Out	7.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	829
Open	0.1560
Previous Close	0.1700
Day's Range	0.1560 - 0.1560
52-Week Range	0.0100 - 0.2200
Beta	2.91
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RegenETP

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, o...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Richard Hague
• Employees: 43
• Stock Exchange: OTCMKTS
• Ticker Symbol: RGTPQ

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Apr 18, 2025

Data Sources Report a data error